These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37208329)

  • 1. ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.
    Xiao X; Shi J; He C; Bu X; Sun Y; Gao M; Xiang B; Xiong W; Dai P; Mao Q; Xing X; Yao Y; Yu H; Xu G; Li S; Ren Y; Chen B; Jiang C; Meng G; Lee YR; Wei W; Freeman GJ; Xie C; Zhang J
    Nat Commun; 2023 May; 14(1):2859. PubMed ID: 37208329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
    Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
    MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP5 facilitates diabetic retinopathy development by stabilizing ROBO4 via deubiquitination.
    Guo H; Liu R; Lv H; Huo Q; Yao Y; Lu X
    Cell Signal; 2024 Aug; 120():111225. PubMed ID: 38735506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor.
    Xu X; Huang A; Cui X; Han K; Hou X; Wang Q; Cui L; Yang Y
    Theranostics; 2019; 9(14):4208-4220. PubMed ID: 31281542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.
    Pan J; Qiao Y; Chen C; Zang H; Zhang X; Qi F; Chang C; Yang F; Sun M; Lin S; Tang Q; Li L; Wang M; Wu M; Liu Y; Lai C; Chen J; Chen G
    Cell Death Dis; 2021 Nov; 12(11):1051. PubMed ID: 34741014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila.
    Ristic G; Tsou WL; Guzi E; Kanack AJ; Scaglione KM; Todi SV
    J Biol Chem; 2016 Apr; 291(17):9161-72. PubMed ID: 26917723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.
    Wang X; Deng X; Hu J; Zheng W; Ye D; Zhou X; Fang L
    Cancer Lett; 2024 Apr; 588():216764. PubMed ID: 38431034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deubiquitinase Leon/USP5 regulates ubiquitin homeostasis during Drosophila development.
    Wang CH; Chen GC; Chien CT
    Biochem Biophys Res Commun; 2014 Sep; 452(3):369-75. PubMed ID: 25152394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
    Yu ZZ; Liu YY; Zhu W; Xiao D; Huang W; Lu SS; Yi H; Zeng T; Feng XP; Yuan L; Qiu JY; Wu D; Wen Q; Zhou JH; Zhuang W; Xiao ZQ
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 37001908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEPDC1B-mediated USP5 deubiquitination of β-catenin promotes breast cancer metastasis by activating the wnt/β-catenin pathway.
    Wang Q; Chen F; Yang N; Xu L; Yu X; Wu M; Zhou Y
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C833-C848. PubMed ID: 37642235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy.
    Kim SB; Hwang S; Cha JY; Lee HJ
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression.
    Peng ZM; Han XJ; Wang T; Li JJ; Yang CX; Tou FF; Zhang Z
    Breast Cancer Res; 2024 Jan; 26(1):10. PubMed ID: 38217030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1-regulated USP5 contributes to the tumorigenic capacity of glioma stem cells through the maintenance of OCT4 stability.
    Jiang X; You H; Niu Y; Ding Y; Chen Z; Wang H; Xu Y; Zhou P; Wei L; Deng D; Xue L; Peng Y; Yang Y; Fan L; Shao N
    Cancer Lett; 2024 Jul; 593():216875. PubMed ID: 38643837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity.
    Li J; Wang Y; Luo Y; Liu Y; Yi Y; Li J; Pan Y; Li W; You W; Hu Q; Zhao Z; Zhang Y; Cao Y; Zhang L; Yuan J; Xiao ZJ
    Nat Commun; 2022 Dec; 13(1):7799. PubMed ID: 36528652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m
    Sun HL; Zhu AC; Gao Y; Terajima H; Fei Q; Liu S; Zhang L; Zhang Z; Harada BT; He YY; Bissonnette MB; Hung MC; He C
    Mol Cell; 2020 Nov; 80(4):633-647.e7. PubMed ID: 33217317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.
    Cheung BB; Kleynhans A; Mittra R; Kim PY; Holien JK; Nagy Z; Ciampa OC; Seneviratne JA; Mayoh C; Raipuria M; Gadde S; Massudi H; Wong IPL; Tan O; Gong A; Suryano A; Diakiw SM; Liu B; Arndt GM; Liu T; Kumar N; Sangfelt O; Zhu S; Norris MD; Haber M; Carter DR; Parker MW; Marshall GM
    Oncogene; 2021 Apr; 40(13):2367-2381. PubMed ID: 33658627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis.
    de Sauvage MA; Torrini C; Nieblas-Bedolla E; Summers EJ; Sullivan E; Zhang BS; Batchelor E; Marion B; Yamazawa E; Markson SC; Wakimoto H; Nayyar N; Brastianos PK
    Neuro Oncol; 2024 May; 26(5):889-901. PubMed ID: 38134951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway.
    Cao L; Liu H; Huang C; Guo C; Zhao L; Gao C; Xu Y; Wang G; Liang N; Li S
    Biol Direct; 2023 Apr; 18(1):16. PubMed ID: 37060095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy.
    Hu X; Wang J; Chu M; Liu Y; Wang ZW; Zhu X
    Mol Ther; 2021 Mar; 29(3):908-919. PubMed ID: 33388422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin ligase UBR4 and the deubiquitylase USP5 modulate the stability of DNA mismatch repair protein MLH1.
    Mao C; Li S; Che J; Liu D; Mao X; Rao H
    J Biol Chem; 2024 Aug; 300(8):107592. PubMed ID: 39032648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.